AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CHLORHYDRATE DE LIDOCAINE

8 registrations across 3 African markets— 7 active

Markets with CHLORHYDRATE DE LIDOCAINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
LIGNOX 2% SOLUTION INJECTABLE FLACON DE 20ML🇨🇮Côte d'IvoireINDOCO REMEDIES LIMITEDexpiredJan 2021
LIDOCAINE UBIGEN
solution injectable / 21.30 mg
🇸🇳SenegalUBITHERA PHARMA PVT LTDactive
XYLOCAINE VISQUEUSE
gel orale / 0,02
🇸🇳SenegalASPENactive
LIDOCAINE WITH EPINEPHRINE INJECTION SI BTE (10 FL X 30ML)
solution injectable, boîte de un
🇲🇬MadagascarCIRON DRUGS &active
LIDOCAINE WITH EPINEPHRINE INJECTION SI BTE (10 FL X 30ML)
solution injectable, boîte de un
🇲🇬MadagascarCIRON DRUGS &active
XYLOCAINE
solution injectable / 20 mg/ml
🇸🇳Senegalactive
XYLOCAINE VISQUEUSE
gel orale / 0,02
🇸🇳SenegalASPENactive
XYLOCAINE
solution injectable / 20 mg/ml
🇸🇳Senegalactive

CHLORHYDRATE DE LIDOCAINE in Africa — Regulatory Overview

CHLORHYDRATE DE LIDOCAINE is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Madagascar, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 8 registrations, 7 (88%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.